Myriad Genetics: George Daneker
Myriad Genetics appointed George Daneker as president and chief clinical officer of oncology, effective March 18. Daneker will be responsible for leading Myriad's commercial and clinical strategy related to its oncology portfolio. Daneker previously served as system VP for oncology and as medical director of the Oncology Clinical Program at SSM Health, a not-for-profit health system. Prior to that, he served as system corporate chief medical officer at City of Hope.